✦ LIBER ✦

Cost effectiveness of high-risk HPV DNA testing for cervical cancer screening in South Africa

✍ Scribed by Arthi Vijayaraghavan; Molly Efrusy; Gerhard Lindeque; Greta Dreyer; Christopher Santas

Book ID: 113961794
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 518 KB
Volume: 112
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2008.08.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of primary HPV screen

Cost-effectiveness of primary HPV screening for cervical cancer in Germany – a decision analysis

✍ G. Sroczynski; P. Schnell-Inderst; N. Mühlberger; K. Lang; P. Aidelsburger; J. W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 582 KB

HPV testing for cervical cancer screenin

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico

✍ Yvonne N. Flores; David M. Bishai; Attila Lőrincz; Keerti V. Shah; Eduardo Lazca 📂 Article 📅 2010 🏛 Springer Netherlands 🌐 English ⚖ 261 KB

## Objective To determine the incremental costs and effects of different HPV testing strategies, when compared to Papanicolau cytology (Pap), for cervical cancer screening in Mexico. ## Methods A cost-effectiveness analysis (CEA) examined the specific costs and health outcomes associated with (1)

PCR-based high-risk HPV test in cervical

PCR-based high-risk HPV test in cervical cancer screening gives objective risk assessment of women with cytomorphologically normal cervical smears

✍ L. Rozendaal; J.M.M. Walboomers; J.C. van der Linden; F.J. Voorhorst; P. Keneman 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 508 KB

Cemcalsancer screening programmes using cytomorphological criteria could be more efficient if the screening included objective individual risk factors for women with normal cytology, such as a test for high-risk human papillomavirus (HPV). The value of a PCR-based test for high-risk HPV types was st

The potential cost-effectiveness of addi

The potential cost-effectiveness of adding a human papillomavirus vaccine to the cervical cancer screening programme in South Africa

✍ Edina Sinanovic; Jennifer Moodley; Mark A. Barone; Sumaya Mall; Susan Cleary; Ja 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Cost-effectiveness analysis of human pap

Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system

✍ Chow, I H-I; Tang, C-H; You, S-L; Liao, C-H; Chu, T-Y; Chen, C-J; Chen, C-A; Pwu 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 548 KB

Evaluation of a new p16INK4A ELISA test

Evaluation of a new p16INK4A ELISA test and a high-risk HPV DNA test for cervical cancer screening: Results from proof-of-concept study

✍ Constance Mao; Akhila Balasubramanian; Mujun Yu; Nancy Kiviat; Ruediger Ridder; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 1 views

## Abstract p16^INK4a^, a cell cycle regulation protein, accumulates in abnormal epithelial cells infected with high‐risk human papilloma virus (HPV). In immunostaining studies, p16^INK4a^ has shown potential as a marker of high grade cervical intraepithelial neoplasia (CIN) and invasive cervical c